Citation: | XIAO Yanan, SUN Jianguo, WAN Ping, WANG Guangji. Pharmacokinetics of(S)-ornidazole and(S)-ornidazole phosphate disodium in rats[J]. Journal of China Pharmaceutical University, 2014, 45(5): 571-575. DOI: 10.11665/j.issn.1000-5048.20140512 |
[1] |
Huttunen KM,Raunio H,Rautio J.Prodrugs—from serendipity to rational design[J].Pharmacol Rev,2011,63(3):750-771.
|
[2] |
Zawilska JB,Wojcieszak J,Olejniczak AB.Prodrugs:a challenge for the drug development[J].Pharmacol Rep,2013,65(1):1-14.
|
[3] |
Stella VJ.Prodrugs:some thoughts and current issues[J].J Pharm Sci,2010,99(12):4 755-4 765.
|
[4] |
Scott FI,Osterman MT.Medical management of Crohn disease[J].Clin Colon Rectal Surg,2013,26(2):67-74.
|
[5] |
Papi C,Fasci SF,Margagnoni G,et al.Randomized controlled trials in prevention of postsurgical recurrence in Crohn′s disease[J].Rev Recent Clin Trials,2012,7(4):307-413.
|
[6] |
Chen K,Sun JH,Wang,ZQ,et al.Different mechanism between ornidazole enantiomers on central nervous system in mice[J].J China Pharm Univ(中国药科大学学报),2012,43(3):271-274.
|
[7] |
Jana S,Mandlekar S,Marathe P.Prodrug design to improve pharmacokinetic and drug delivery properties:challenges to the discovery scientists[J].Curr Med Chem,2010,17(32):3 874-3 908.
|
[8] |
Marat DM,Romari Am,Mariela N,et al.Biomarkers of genotoxicity and genomic instability in a non-human primate,Cebus libidinosus (Cebidae,Platyrrhini),exposed to nitroimidazole derivatives[J].Mutat Res,2011,721(1):108-113.
|
[9] |
Menendez D,Rojas E,Herrera LA,et al.DNA breakage due to metronidazole treatment[J].Mutat Res,2001,478(1/2):153-158.
|
[10] |
Muller J,Schildknecht P,Muller N.Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia:characterization of a novel nitroreductase(GlNR2)[J].J Antimicrob Chemother,2013,68(8):1 781-1 789.
|
[11] |
Lopez NMM,Palermo AM,Mudry MD,et al.Cytogenetic evaluation of two nitroimidazole derivatives[J].Toxicol In Vitro,2003,17(1):35-40.
|
[12] |
Zhu YC,Sun JG,Peng Y,et al.Research on the pharmacokinetics of prodrug[J].Chin J Clin Pharmacol Ther(中国临床药理学与治疗学),2012,(12):1 433-1 440.
|
[13] |
Feng D,Sun JG,Zhu YC,et al.Pharmacokinetics of a novel antihypertension candidate ATPT in Beagle dogs[J].J China Pharm Univ(中国药科大学学报),2013,44(2):151-155.
|
[14] |
Duan YB, Zhang SB, Liu S, et al. Study on pharmacokinetics methodlogy of S-(-)oornifazol disodium phosphate[J].J Southeast Univ(Med Sci Ed)(东南大学学报 医学版),2011,30(2):312-315.
|